ADVANCED RENAL CELL CARCINOMA
Clinical trials for ADVANCED RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Electric field therapy worn like a vest shows promise against tough cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates low-intensity electric fields to disrupt cancer cell growth, combined with standard drugs (cabozantinib or nab-paclitaxel plus atezolizumab). About 43 adults with advanced solid tumors in the abdomen or chest that have s…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:02 UTC
-
New hope for advanced kidney cancer: experimental drug enters human trials
Disease control Recruiting nowThis study tests a new medicine, PF-08634404, in adults with advanced kidney cancer that has spread. The goal is to see if it is safe and can shrink tumors when given alone or with other cancer drugs. About 224 participants will receive the drug through an IV. This is an early-ph…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for kidney cancer patients whose first treatment stopped working
Disease control Recruiting nowThis study tests a new drug called zanzalintinib, alone or with an immunotherapy (nivolumab), in people with advanced kidney cancer that got worse after standard first treatment. About 70 adults will take part. The goal is to see if the combination can shrink tumors or slow the d…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Karie Runcie • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Cord blood cells engineered to fight three tough cancers enter human trials
Disease control Recruiting nowThis study tests a new treatment for people with advanced kidney cancer, mesothelioma, or bone cancer. It uses donated cord blood cells that are specially trained to attack cancer cells. These cells are given along with chemotherapy that lowers the body's immune defenses. The goa…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New hope for advanced kidney cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a combination of three drugs (SHR-8068, adebrelimab, and others) in 139 adults with advanced kidney cancer that cannot be removed by surgery or has spread. The goal is to see if the treatment can shrink tumors and control the disease. Participants must provide a …
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Cancer care at home: a game changer for patients?
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for people with advanced cancers. The goal is to see if home treatment reduces stress, financial burden, and improves the overall experience. About 220 participants will be randomly assigned to receive their t…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 04:08 UTC
-
Morning or afternoon? new study tests best time for cancer immunotherapy
Symptom relief Recruiting nowThis study is testing whether getting immunotherapy in the morning or the afternoon makes it work better for people with advanced or metastatic solid tumors like lung, kidney, or skin cancer. Researchers think the body's internal clock might affect how the immune system responds.…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE4 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated May 26, 2026 03:56 UTC
-
Cancer patients may soon get infusions at home, cutting travel and stress
Symptom relief Recruiting nowThis study tests whether giving the cancer drug nivolumab as a shot at home is as safe and effective as getting it in a clinic. About 50 adults with various cancers will try both settings to see which they prefer and how it affects their quality of life. The goal is to reduce the…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 03:53 UTC